MYLAN 5375 MYLAN 5375 (Doxepin 75 mg)
Pill imprint MYLAN 5375 MYLAN 5375 has been identified as Doxepin hydrochloride 75 mg.
Doxepin is used in the treatment of insomnia; anxiety; urticaria; irritable bowel syndrome; reflex sympathetic dystrophy syndrome (and more), and belongs to the drug classes miscellaneous anxiolytics, sedatives and hypnotics, tricyclic antidepressants. FDA has not classified the drug for risk during pregnancy. Doxepin 75 mg is not a controlled substance under the Controlled Substance Act (CSA).
- MYLAN 5375 MYLAN 5375
- 75 mg
- 18.00 mm
- Prescription only
- Drug Class:
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
D&C Yellow No. 10
FD&C Green No. 3
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
|NDC Code||Manufacturer / Repackager|
|51079-0645||UDL Laboratories Inc|
|58016-0797||Southwood Pharmaceuticals Inc (repackager)|
|16590-0485||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about doxepin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.